Tech Company Financing Transactions

IFM Therapeutics Funding Round

IFM Therapeutics closed a $27 million Series A funding round on 6/23/2016. Backers included Abingworth, Atlas Accelerator and Novartis Venture Fund.

Transaction Overview

Company Name
Announced On
6/23/2016
Transaction Type
Venture Equity
Amount
$27,000,000
Round
Series A
Investors

Abingworth (Lead Investor) (Vincent Miles)

Atlas Accelerator (Lead Investor) (Jean-François Formela)

Novartis Venture Fund

Proceeds Purpose
The company will use the proceeds of the financing to advance and expand its early-stage portfolio and begin clinical development of its most advanced product candidate, a selective activator of a novel target, for treating solid tumors.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
855 Boylston St. 11th Floor
Boston, MA 02116
USA
Email Address
Overview
At IFM Therapeutics, we are driven to invent transformative therapies to improve the lives of patients with serious, life threatening diseases. We are passionate about building a company that embraces creativity, integrity, and excellence.
Profile
IFM Therapeutics LinkedIn Company Profile
Social Media
IFM Therapeutics Company Twitter Account
Company News
IFM Therapeutics News
Facebook
IFM Therapeutics on Facebook
YouTube
IFM Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chairman
Gary Glick
  Gary Glick LinkedIn Profile  Gary Glick Twitter Account  Gary Glick News  Gary Glick on Facebook
Chief Executive Officer
Martin Seidel
  Martin Seidel LinkedIn Profile  Martin Seidel Twitter Account  Martin Seidel News  Martin Seidel on Facebook
Vice President
Ed Olhava
  Ed Olhava LinkedIn Profile  Ed Olhava Twitter Account  Ed Olhava News  Ed Olhava on Facebook
VP - Bus. Development
Dennis Dean
  Dennis Dean LinkedIn Profile  Dennis Dean Twitter Account  Dennis Dean News  Dennis Dean on Facebook
VP - Operations
Lina Gugucheva
  Lina Gugucheva LinkedIn Profile  Lina Gugucheva Twitter Account  Lina Gugucheva News  Lina Gugucheva on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/23/2016: PreNav venture capital transaction
Next: 6/23/2016: iZotope venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on tech company VC transactions. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary